Felipe Nör1, Carolina Nör2, Letícia W Bento3, Zhaocheng Zhang3, Walter A Bretz4, Jacques E Nör5. 1. Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA; Department of Oral Pathology, Radiology & Medicine, University of Iowa College of Dentistry, Iowa City, IA, USA. Electronic address: felipe-nor@uiowa.edu. 2. Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA; Programme in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, ON, Canada. 3. Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA. 4. Microsolum, Huntington Beach, CA, USA. 5. Department of Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA; Department of Biomedical Engineering, University of Michigan College of Engineering, Ann Arbor, MI, USA; Department of Otolaryngology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Abstract
OBJECTIVE: To evaluate the effect of Brazilian propolis on head and neck cancer stem cells in vitro. METHODS: Head and neck squamous cell carcinoma (HNSCC) cell lines (UM-SCC-17B and UM-SCC-74A), human keratinocytes (HK), and primary human dermal microvascular endothelial cells (HDMEC) were treated with 0.5, 5.0, or 50 μg/mL green, brown or red Brazilian propolis or vehicle control for 24, 36, and 72 h. Cell viability was evaluated by Sulforhodamine B assay. Western blots evaluated expression of cancer stem cell (CSC) markers (i.e. ALDH, CD44, Oct-4, Bmi-1) and flow cytometry was performed to determine the impact of propolis in the fraction of CSC, defined as ALDHhighCD44high cells. RESULTS: propolis significantly reduced cell viability of HNSCC and HDMEC cells, but not HK. Notably, red propolis caused a significant reduction in the percentage of CSC, reduced the number of orospheres, and downregulated the expression of stem cell markers. CONCLUSIONS: Collectively, our data demonstrate an anti-CSC effect of propolis, and suggest that propolis (i.e. red propolis) might be beneficial for patients with head and neck cancer.
OBJECTIVE: To evaluate the effect of Brazilian propolis on head and neck cancer stem cells in vitro. METHODS: Head and neck squamous cell carcinoma (HNSCC) cell lines (UM-SCC-17B and UM-SCC-74A), human keratinocytes (HK), and primary human dermal microvascular endothelial cells (HDMEC) were treated with 0.5, 5.0, or 50 μg/mL green, brown or red Brazilian propolis or vehicle control for 24, 36, and 72 h. Cell viability was evaluated by Sulforhodamine B assay. Western blots evaluated expression of cancer stem cell (CSC) markers (i.e. ALDH, CD44, Oct-4, Bmi-1) and flow cytometry was performed to determine the impact of propolis in the fraction of CSC, defined as ALDHhighCD44high cells. RESULTS: propolis significantly reduced cell viability of HNSCC and HDMEC cells, but not HK. Notably, red propolis caused a significant reduction in the percentage of CSC, reduced the number of orospheres, and downregulated the expression of stem cell markers. CONCLUSIONS: Collectively, our data demonstrate an anti-CSC effect of propolis, and suggest that propolis (i.e. red propolis) might be beneficial for patients with head and neck cancer.
Authors: X León; R Hitt; M Constenla; A Rocca; R Stupp; A F Kovács; N Amellal; E H Bessa; J Bourhis Journal: Clin Oncol (R Coll Radiol) Date: 2005-09 Impact factor: 4.126
Authors: David Díaz-Carballo; Ali Haydar Acikelli; Walter Bardenheuer; Sebastian Gustmann; Sascha Malak; Raphael Stoll; Thorsten Kedziorski; Mhd Ali Nazif; Holger Jastrow; Gunter Wennemuth; Philip Dammann; Martin Feigel; Dirk Strumberg Journal: Int J Clin Pharmacol Ther Date: 2014-09 Impact factor: 1.366
Authors: Katarzyna Celińska-Janowicz; Ilona Zaręba; Urszula Lazarek; Joanna Teul; Michał Tomczyk; Jerzy Pałka; Wojciech Miltyk Journal: Front Pharmacol Date: 2018-04-06 Impact factor: 5.810
Authors: Sandra Aparecida Lima de Moura; Mônica Alves Neves Diniz Ferreira; Silvia Passos Andrade; Maria Leticia Costa Reis; Maria de Lourdes Noviello; Denise Carmona Cara Journal: Evid Based Complement Alternat Med Date: 2011-03-09 Impact factor: 2.629